Annual Current Assets
$347.29 M
+$61.53 M+21.53%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual total current assets is $347.29 million, with the most recent change of +$61.53 million (+21.53%) on December 31, 2023.
- During the last 3 years, KROS annual current assets has risen by +$79.57 million (+29.72%).
- KROS annual current assets is now at all-time high.
Performance
KROS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$552.05 M
+$119.33 M+27.58%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly total current assets is $552.05 million, with the most recent change of +$119.33 million (+27.58%) on September 30, 2024.
- Over the past year, KROS quarterly current assets has increased by +$204.75 million (+58.96%).
- KROS quarterly current assets is now at all-time high.
Performance
KROS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
KROS Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +21.5% | +59.0% |
3 y3 years | +29.7% | +144.2% |
5 y5 years | +1260.3% | - |
KROS Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +38.1% | at high | +148.3% |
5 y | 5-year | at high | +3790.4% | at high | +6084.0% |
alltime | all time | at high | +3790.4% | at high | +6084.0% |
Keros Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $552.05 M(+27.6%) |
Jun 2024 | - | $432.71 M(-6.6%) |
Mar 2024 | - | $463.13 M(+33.4%) |
Dec 2023 | $22.73 M(+8.2%) | $347.29 M(+14.1%) |
Sep 2023 | - | $304.44 M(-8.9%) |
Jun 2023 | - | $334.31 M(-7.7%) |
Mar 2023 | - | $362.22 M(+26.8%) |
Dec 2022 | $21.01 M | $285.77 M(+16.2%) |
Sep 2022 | - | $245.88 M(+10.6%) |
Jun 2022 | - | $222.36 M(-3.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $231.22 M(-8.0%) |
Dec 2021 | $3.81 M(+122.0%) | $251.44 M(+11.2%) |
Sep 2021 | - | $226.07 M(-6.4%) |
Jun 2021 | - | $241.42 M(-5.7%) |
Mar 2021 | - | $255.98 M(-4.4%) |
Dec 2020 | $1.72 M(-15.3%) | $267.73 M(+96.3%) |
Sep 2020 | - | $136.42 M(-8.1%) |
Jun 2020 | - | $148.52 M(+153.7%) |
Mar 2020 | - | $58.54 M(+555.8%) |
Dec 2019 | $2.03 M(+7.8%) | $8.93 M |
Dec 2018 | $1.88 M | - |
FAQ
- What is Keros Therapeutics annual total current assets?
- What is the all time high annual current assets for Keros Therapeutics?
- What is Keros Therapeutics annual current assets year-on-year change?
- What is Keros Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Keros Therapeutics?
- What is Keros Therapeutics quarterly current assets year-on-year change?
What is Keros Therapeutics annual total current assets?
The current annual current assets of KROS is $347.29 M
What is the all time high annual current assets for Keros Therapeutics?
Keros Therapeutics all-time high annual total current assets is $347.29 M
What is Keros Therapeutics annual current assets year-on-year change?
Over the past year, KROS annual total current assets has changed by +$61.53 M (+21.53%)
What is Keros Therapeutics quarterly total current assets?
The current quarterly current assets of KROS is $552.05 M
What is the all time high quarterly current assets for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total current assets is $552.05 M
What is Keros Therapeutics quarterly current assets year-on-year change?
Over the past year, KROS quarterly total current assets has changed by +$204.75 M (+58.96%)